Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Ann Surg
    November 2025
  1. RAFTERY NB, Elliott JA, Muldoon C, Ryan C, et al
    Tackling Prevention and Early Diagnosis of Esophageal Adenocarcinoma Through a National Barrett's Registry and Scientific Network.
    Ann Surg. 2025;282:742-749.
    >> Share

  2. SMYTH E, O'Neill LM, Kearney N, Sheill G, et al
    Preoperative Exercise to Improve Fitness in Patients Undergoing Complex Surgery for Cancer of the Lung or Esophagus (PRE-HIIT): A Randomized Controlled Trial.
    Ann Surg. 2025;282:690-698.
    >> Share

    September 2025
  3. WANG J, Wu Z, Verhoeven RHA, Goense L, et al
    A Novel TRG-N Prognostic Classification System for Esophageal Cancer Undergoing Neoadjuvant Therapy Followed by Esophagectomy: A Study Based on the Netherlands Cancer Registry.
    Ann Surg. 2025 Sep 23. doi: 10.1097/SLA.0000000000006869.
    >> Share

    August 2025
  4. OKUI J, Matsuda S, Nagashima K, Sato Y, et al
    Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer: Integrated Analysis of Individual Patient Data From Phase III Trials.
    Ann Surg. 2025 Aug 25. doi: 10.1097/SLA.0000000000006919.
    >> Share

  5. ANTUNEZ AG, Sinco BR, Saucke MC, Bushaw KJ, et al
    Making Choices: A Multi-institutional, Longitudinal Cohort Study Assessing Changes in Treatment Outcome Valuation for Low-risk Thyroid Cancer.
    Ann Surg. 2025;282:275-282.
    >> Share

    July 2025
  6. FEENSTRA ML, Kooij CD, Eshuis WJ, de Groot EM, et al
    Paravertebral Versus EPidural Analgesia in Minimally Invasive Esophageal ResectioN (PEPMEN): A Randomized Controlled Multicenter Trial.
    Ann Surg. 2025;282:29-36.
    >> Share

    June 2025
  7. NAKAUCHI M, Walch HS, Nussenzweig S, Carr R, et al
    Genomic Landscape of Adenocarcinomas Across the Gastroesophageal Junction: Moving on From the Siewert Classification.
    Ann Surg. 2025;281:989-996.
    >> Share

    March 2025
  8. TAKEI S, Kotani D, Laliotis G, Sato K, et al
    Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study.
    Ann Surg. 2025 Mar 21. doi: 10.1097/SLA.0000000000006699.
    >> Share

  9. NA KJ, Kang CH, Kim YR, Kang MJ, et al
    Comparison of Clinical Outcomes and Postoperative Nutritional Status Between Early and Late Oral Feeding After Esophagectomy: An Open Labeled Randomized Controlled Trial.
    Ann Surg. 2025;281:388-394.
    >> Share

    November 2024
  10. SIHAG S
    Real-world Application of Endoscopic Resection for Early-stage Esophageal Cancer: do we need to rethink the guidelines?
    Ann Surg. 2024 Nov 20. doi: 10.1097/SLA.0000000000006593.
    >> Share

  11. PUCCETTI F, Cinelli L, Barbieri LA, Socci D, et al
    The Near-Infrared Visualization and Preemptive Ligation of the Thoracic Duct Effectively Reduce the Chyle Leak Incidence After Minimally Invasive Esophagectomy.
    Ann Surg. 2024;280:780-787.
    >> Share

  12. WIRSIK NM, Kooij CD, Dempster N, Crnovrsanin N, et al
    Optimal Treatment Strategies for cT2 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A Multinational, High-volume Center Retrospective Cohort Analysis.
    Ann Surg. 2024;280:799-807.
    >> Share

    October 2024
  13. MARKAR SR, Sgromo B, Evans R, Griffiths EA, et al
    The Prognostic Impact of Minimally Invasive Esophagectomy on Survival After Esophagectomy Following a Delayed Interval After Chemoradiotherapy: A Secondary Analysis of the DICE Study.
    Ann Surg. 2024;280:650-658.
    >> Share

    September 2024
  14. PUCHER PH, Rahman SA, Bhandari P, Blencowe N, et al
    Prevalence and Risk Factors for Malignant Nodal Involvement in Early esophago-gastric Adenocarcinoma: Results from the Multicenter Retrospective Congress Study (endosCopic resectiON, esophaGectomy or Gastrectomy For Early Esophagogastric Cancers).
    Ann Surg. 2024 Sep 2. doi: 10.1097/SLA.0000000000006496.
    >> Share

    August 2024
  15. DONLON NE, Moran B, Davern M, Davey MG, et al
    Evidence for the Positive Impact of Centralization in Esophageal Cancer Surgery.
    Ann Surg. 2024 Aug 13. doi: 10.1097/SLA.0000000000006487.
    >> Share

  16. OVERTOOM HCG, Eyck BM, van der Wilk BJ, Noordman BJ, et al
    Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
    Ann Surg. 2024 Aug 13. doi: 10.1097/SLA.0000000000006488.
    >> Share

  17. WANG J, de Jongh C, Wu Z, de Groot EM, et al
    Impact of Preoperative Time Intervals for Neoadjuvant Chemoradiotherapy on Short-term Postoperative Outcomes of Esophageal Cancer Surgery: A Population-Based Study Using the Dutch Upper Gastrointestinal Cancer Audit (DUCA) Data.
    Ann Surg. 2024 Aug 8. doi: 10.1097/SLA.0000000000006476.
    >> Share

    July 2024
  18. DEBOEVER N, Correa AM, Feldman H, Eisenberg M, et al
    Early Interventional Treatment of High Output Chyle Leak After Esophagectomy is Associated With Improved Survival.
    Ann Surg. 2024;280:91-97.
    >> Share

    April 2024
  19. HENCKENS SP, Schuring N, Elliott JA, Johar A, et al
    Recurrence and Survival after Minimally Invasive and Open Esophagectomy for Esophageal Cancer - A Post Hoc Analysis of the Ensure Study.
    Ann Surg. 2024 Apr 5. doi: 10.1097/SLA.0000000000006280.
    >> Share

    March 2024
  20. AIOLFI A, Bona D, Bonitta G, Bonavina L, et al
    Short-term Outcomes of Different Techniques for Gastric Ischemic Preconditioning Before Esophagectomy: A Network Meta-analysis.
    Ann Surg. 2024;279:410-418.
    >> Share

    January 2024
  21. PARK SY, Park B, Yun JK, Kim HR, et al
    Proposal of New ypStage Grouping System for Esophageal Squamous Cell Carcinoma Patients who Underwent Neoadjuvant Chemoradiotherapy followed by Surgery.
    Ann Surg. 2024 Jan 17. doi: 10.1097/SLA.0000000000006204.
    >> Share

    December 2023
  22. KARALIS JD, Ju MR, Yoon LY, Castro-Dubon EC, et al
    Serum Interleukin 6 Level is Associated With Overall Survival and Treatment Response in Gastric and Gastroesophageal Junction Cancer.
    Ann Surg. 2023;278:918-924.
    >> Share

  23. OWEN RP, Chidambaram S, Griffiths EA, Sultan J, et al
    Multicenter, Prospective Cohort Study of Oesophageal Injuries and Related Clinical Outcomes (MUSOIC study).
    Ann Surg. 2023;278:910-917.
    >> Share

    November 2023
  24. WIRSIK NM, Schmidt T, Nienhuser H, Donlon NE, et al
    Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-volume Center Retrospective Cohort Analysis.
    Ann Surg. 2023;278:683-691.
    >> Share

  25. VEZIANT J, Boudis F, Lenne X, Bruandet A, et al
    Outcomes Associated With Esophageal Perforation Management: Results From a French Nationwide Population-based Cohort Study.
    Ann Surg. 2023;278:709-716.
    >> Share

  26. ELLIOTT JA, Klevebro F, Mantziari S, Markar SR, et al
    Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE Study.
    Ann Surg. 2023;278:692-700.
    >> Share

  27. HWANG H, Choi JY, Yu HW, Moon JH, et al
    Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort Study.
    Ann Surg. 2023;278:e1087-e1095.
    >> Share

    June 2023

  28. Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-world Multicenter Study: Erratum.
    Ann Surg. 2023;277:e1397.
    >> Share

    May 2023
  29. BOERNER T, Harrington C, Tan KS, Adusumilli PS, et al
    Waiting to Operate: The Risk of Salvage Esophagectomy.
    Ann Surg. 2023;277:781-788.
    >> Share

  30. YAN L, Liu Y, Li W, Zhu Y, et al
    Long-term Outcomes of Ultrasound-guided Thermal Ablation for the Treatment of Solitary Low-risk Papillary Thyroid Microcarcinoma: A Multicenter Retrospective Study.
    Ann Surg. 2023;277:846-853.
    >> Share

  31. BAYLEY EM, Ivy ML, Shewale JB, Ge PS, et al
    High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed.
    Ann Surg. 2023;277:721-726.
    >> Share


  32. Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA).
    Ann Surg. 2023;277:e1026-e1034.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016